West Pharmaceutical Services (WST) Revenue — Quarter Ended Mar 31, 2025
Revenue for the quarter was virtually unchanged compared with the same quarter one year earlier. However, it declined sequentially from the immediately preceding quarter.
Key takeaway
Quarter ended Mar 31, 2025 · FY2025 Q1
Revenue for the quarter was virtually unchanged compared with the same quarter one year earlier. However, it declined sequentially from the immediately preceding quarter.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$698M
Revenue reported for this quarter.
Quarter-over-quarter
-6.8%
Change from the immediately preceding quarter.
Year-over-year
+0.4%
Change from the comparable year-ago quarter.
Trailing four quarters
$2.9B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2024 | $702.1M | -6.9% |
| Sep 30, 2024 | $746.9M | -0.1% |
| Dec 31, 2024 | $748.8M | +2.3% |
| Mar 31, 2025 | $698M | +0.4% |
Revenue performance
Reported revenue was slightly higher than the same period last year, reflecting a marginal year-over-year increase.
Quarterly comparison
Compared with the prior quarter, revenue decreased, reversing the upward trend seen across the previous three quarters. The year-ago comparison shows a modest improvement.
What to watch
The sequential decline in revenue may warrant attention to near-term demand trends.